KEMYTH BIOTECH CO LTD has a total of 12 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Taiwan and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are MILLENNIUM BIOTHERAPEUTICS INC, DELTA BIOTECHNOLOGY LTD and COMPOUND THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Taiwan | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Siu Leung-Kei | 11 |
#2 | Chang Feng-Yee | 9 |
#3 | Chong Pele Choi-Sing | 9 |
#4 | Leng Chih-Hsiang | 9 |
#5 | Tsai Yu-Kuo | 2 |
#6 | Leng Chih Hsiang | 1 |
#7 | Siu Leung Kei | 1 |
#8 | Chong Pele Choi Sing | 1 |
#9 | Chang Feng Yee | 1 |
Publication | Filing date | Title |
---|---|---|
US2018245125A1 | Antibiotic testing and screening system | |
CN109071614A | Pneumolysin wins peptide as the purposes of the antagonist of confrontation four type of class tongued bell acceptor control and the method for treating four type related disease of class tongued bell acceptor control |